Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director Dealings

21 Jul 2010 13:22

RNS Number : 6966P
BrainJuicer Group PLC
21 July 2010
 



 

 

 

Press Release

21 July 2010

 

 

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Director Dealing

 

 

John Kearon, the Company's Chief Executive Officer has today agreed to borrow £650,000 from third party lenders (the "Lenders"). John Kearon has granted security to the Lenders over 400,000 ordinary shares in the Company beneficially owned by him. The Lenders also have the right to convert the loan into 400,000 ordinary shares at a price per share of £1.625 at any time prior to repayment except during Closed Periods of the Company.

 

The loan is due for repayment in one sum on the fourth anniversary of the commencement date. John Kearon has the right to repay the loan at any time and also has the right to force conversion of the loan at any time subject mid price of BrainJuicer Ordinary Shares being in excess of £2.55 for 20 consecutive trading days and (b) the John Kearon giving 20 London business days' notice to the Lenders. The interest rate is 4% p.a. payable semi-annually in arrears.

 

Up to the date of conversion, if exercised, John Kearon will retain the right to receive any dividends or other distributions declared and will retain the voting rights to the 400,000 ordinary shares. Accordingly, John Kearon's beneficial holding in the Company currently remains unchanged as a result of the above transaction.

 

- Ends -

 

For further information, please contact:

BrainJuicer Group PLC

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Mark Williams / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFFDLILFII
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.